Results 121 to 130 of about 145,229 (269)

Assessing adoption of human and AI-enabled diabetic retinopathy screening in primary healthcare settings: findings from a pragmatic trial

Archives of Public Health
Introduction Diabetic retinopathy (DR) screening with defined referral pathways is essential for early detection and effective management of DR. This study assessed the adoption of three DR screening (DRS) models in primary healthcare settings, focusing ...
Anshul Chauhan, Luke Vale, Ankita Kankaria, Vishali Gupta, Gagandeep Kaur, Neha N., Nayanshi Sood, Basavaraj Tigari, Sanjay Bhadada, Mona Duggal   +9 more
doaj   +1 more source

IL‐2 silencing enables Tfh cell expansion during vaccination but is redundant for antibody production

Immunology &Cell Biology, EarlyView.
Sustained IL‐2 production delays T follicular helper cell differentiation and germinal center formation but does not alter final antibody titers or antigen‐specific humoral immunity after vaccination. Created in BioRender. Burton, A. (2026) https://BioRender.com/paggz41 Abstract Vaccines stimulate protective humoral immunity by coordinating lymphocyte ...
Silvia Innocentin, Ross McKenzie, Jayalini Assalaarachchi, Helena A Carslaw, Anusha Gupta, Sanne Cole, Adrian Liston, Michelle A Linterman, Louise Webb, Alice R Burton   +9 more
wiley   +1 more source

Auto‐inducible expression of chimeric antigen receptor T cells using the NR4A1 promoter

Immunology &Cell Biology, EarlyView.
The NR4A1 promoter is a compact auto‐inducible promoter to drive CAR expression in T cells. Compared with EF1α, or existing synthetic antigen‐inducible promoters, NR4A1 is more compact and ensures that resting CAR T cells express reduced baseline CAR. NR4A1 allows rapid induction upon antigen encounter with reduced T‐cell exhaustion.
Samuel WJ Smith‐Bell, Joshua C Halpin, Phillip K Darcy, Thiloma Liyanage, Lachlan J Dobson, Alexander D McLellan   +5 more
wiley   +1 more source

Eco-turismo como un medio de desarrollo comunitario: El caso de la población indígena del Gran Caribe

ARA: Revista de Investigación en Turismo, 2017
El mercado mundial ofrece muchas clases de turismo con tipologías tan diversas como las experiencias demandadas por los turistas. Los destinos se especializan en modelos turísticos que satisfacen las necesidades y deseos del mercado turístico al cual ...
Jasmin Garraway
doaj  

‘It's Like a Horror Movie That You Walk Through’: Experiencing Horror Through Immersive Recreation

The Journal of American Culture, EarlyView.
ABSTRACT Horror stories have provided enjoyable forms of leisure for centuries. Over the past five decades, however, these experiences have evolved into increasingly immersive forms of popular culture. What once involved constructing the narrative world internally through reading has expanded into sensory engagement through visual and auditory media ...
Susan Weidmann
wiley   +1 more source

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda, B. Tedbirt, C. Bodemer, M. C. Bolling, M. El Hachem, M. Nikolić, E. Benton, M. Caproni, D. De, D. Didona, K. Drenovska, M. Goebeler, M. Hertl, B. Horváth, M. Kasperkiewicz, D. Kiritsi, M. Larralde, A. V. Marzano, J. Meijer, D. F. Murrell, J. Powell, E. Sprecher, N. S. Chandran, M. M. Tomayko, S. Uzun, N. van Beek, H. Ott, A. Patsatsi, A. Torrelo, A. Welfringer‐Morin, E. Schmidt, P. Joly   +31 more
wiley   +1 more source

Anticholinergic Medication Burden Scales: A Systematic Review

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Anticholinergic burden refers to the cumulative anticholinergic effect of all medications taken by an individual. Anticholinergic burden scales help identify patients at risk of anticholinergic adverse effects and guide prescribing. However, substantial variation exists between scales, with no gold standard identified.
Orla Vennard, Carrie Stewart, Mansi Tolia, Roy L. Soiza, Phyo K. Myint   +4 more
wiley   +1 more source

The Importance of Patient Positioning in Radiography When Utilising Automatic Exposure Control. [PDF]

J Med Radiat Sci
This study highlights the impact of inaccurate patient positioning on dose and image quality when utilising the automatic exposure control (AEC) for radiographic examinations. While the AEC serves to optimise radiation dose to patients, the results here demonstrate that poor positioning can lead to significant dose implications for patients.
Steward A, Do C, Brazil T, Barresi M.
europepmc   +2 more sources

Life Course Trajectories of Body Mass Index and Risk of Cancer in Adulthood: Systematic Review and Meta‐Analysis

Obesity Reviews, EarlyView.
ABSTRACT Objective This systematic review and meta‐analysis aimed to identify common life‐course body mass index (BMI) trajectories (childhood/adulthood to adulthood) and their impact on risk of cancer overall and cancer at different sites in adulthood. Methods Observational studies were identified that assessed the association of BMI trajectories with
Samira Behboudi‐Gandevani, Tommy Haugan, Nayla Cristina Do Vale Moreira, Ellen Christin Arntzen, Moira Strand Hutchinson, Melanie Nichols, Razieh Bidhendi‐Yarandi   +6 more
wiley   +1 more source

Long‐Term Safety and Efficacy of Once‐Daily and Proactive Twice‐Weekly Roflumilast Cream 0.05% for Mild‐to‐Moderate Atopic Dermatitis in Children Aged 2–5 Years From a 52‐Week, Phase 3 Trial (INTEGUMENT‐OLE)

Pediatric Dermatology, EarlyView.
ABSTRACT Background INTEGUMENT‐PED/NCT04845620, a 4‐week, phase 3 trial, demonstrated efficacy and safety of roflumilast cream 0.05% in children aged 2–5 years with mild‐to‐moderate atopic dermatitis (AD). A phase 3 open‐label extension trial (INTEGUMENT‐OLE [NCT04804605]) investigated long‐term outcomes continuing roflumilast cream for ≤ 56 weeks ...
Lawrence F. Eichenfield, Mercedes E. Gonzalez, Mark Boguniewicz, Tracy Funk, Adelaide A. Hebert, Vimal H. Prajapati, Chesahna Kindred, Rocco Serrao, Lisa Swanson, David Krupa, Scott Snyder, Melissa S. Seal, Diane Hanna, Patrick Burnett, David R. Berk   +14 more
wiley   +1 more source